HomeRVVTF • OTCMKTS
add
Revive Therapeutics Ltd
Previous close
$0.013
Day range
$0.011 - $0.015
Year range
$0.0052 - $0.025
Market cap
8.37M CAD
Avg Volume
245.40K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
CNN
5 days ago
Nasdaq and S&P just had their worst month since March. Here’s how to navigate the shift
0.49%
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 283.30K | -2.05% |
Net income | -238.72K | 34.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -283.25K | 2.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.88K | -76.75% |
Total assets | 261.38K | -97.31% |
Total liabilities | 4.00M | 20.50% |
Total equity | -3.74M | — |
Shares outstanding | 435.68M | — |
Price to book | -1.25 | — |
Return on assets | -277.10% | — |
Return on capital | 19.94% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -238.72K | 34.54% |
Cash from operations | -8.07K | 96.29% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -8.07K | 96.29% |
Free cash flow | 49.22K | 212.84% |
About
Founded
2012
Headquarters
Website
